- Home
- ALPS vs OVID Comparison
ALPS vs OVID Comparison
Compare ALPS & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.56
Company Overview
Basic Information| Metric | ALPS | OVID |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.5M | 117.3M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALPS | OVID |
|---|---|---|
| Price | $1.25 | $1.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.60 |
| AVG Volume (30 Days) | 1.0M | ★ 1.7M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,610,000.00 |
| Revenue This Year | N/A | $1,081.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 945.89 |
| 52 Week Low | $0.56 | $0.24 |
| 52 Week High | $15.00 | $2.01 |
Technical Indicators
Market Signals| Indicator | ALPS | OVID |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.69 |
| Support Level | N/A | $1.21 |
| Resistance Level | N/A | $1.82 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 0.00 | 63.29 |
Price Performance
Historical Comparison ALPS
OVID
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.